MRI shows drugs that can prevent heart damage in breast cancer patients

Researchers who led a new landmark clinical trail using carding MRI found that combining heart medication with chemotherapy reduces the risk of heart damage in patients with early-stage breast cancer.

The new five year study at the University of Alberta and Alberta Health Services found that beta blockers and ACE inhibitors, effectively prevent a drop in heart function from cancer treatment.  

The study is funded by the Canadian Institutes of Health Research (CIHR) and Alberta Cancer Foundation.  

Read the full article here:

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.